As filed with the Securities and Exchange Commission on April 8, 2022
Registration No. 333-
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
REGISTRATION STATEMENT
UNDER
THE SECURITIES ACT OF 1933
(Exact name of Registrant as specified in its charter)
Delaware | | 06-1681204 |
(State or other jurisdiction of incorporation or organization) | | (I.R.S. Employer Identification Number) |
235 Yorkland Blvd, Suite 900, Toronto, Ontario | | M2J 4Y8 |
(Address of Principal Executive Offices) | | (Zip Code) |
Venus Concept Inc. 2019 Incentive Award Plan
(Full Title of the Plan)
Michael Mandarello
General Counsel and Corporate Secretary
Venus Concept Inc.
235 Yorkland Boulevard, Suite 900
Toronto, Ontario M2J 4Y8
(877) 848-8430
(Name, address, including zip code, and telephone number, including area code, of agent for service)
Copies to:
Richard Raymer, Esq.
Dorsey & Whitney LLP
161 Bay Street, Suite 4310
Toronto, ON M5J 2S1
Telephone: (416) 367-7388
Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company or an emerging growth company. See the definitions of “large accelerated filer,” “accelerated filer,” “smaller reporting company” and “emerging growth company” in Rule 12b-2 of the Exchange Act.
Large accelerated filer | ☐ | Accelerated filer | ☐ |
Non-accelerated filer | ☒ | Smaller reporting company | ☒ |
| | Emerging growth company | ☒ |
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 7(a)(2)(B) of the Securities Act. ☐
EXPLANATORY NOTE
This Registration Statement on Form S-8 is being filed for the purpose of registering an additional 2,559,303 shares of Common Stock of Venus Concept Inc. (the “Registrant”) issuable under the Venus Concept Inc. 2019 Incentive Award Plan (the “2019 Plan”), none of which have been issued as of the date of this Registration Statement. These additional shares of Common Stock are securities of the same class as other securities for which the original registration statement on Form S-8 was filed with the Securities and Exchange Commission (the “SEC”) on December 13, 2019 (File No. 333-235480) and remains effective.
These additional shares of Common Stock have become reserved for issuance as a result of the operation of the automatic annual increase provision of the 2019 Plan. The 2019 Plan provides that the total number of shares subject to such plan will be increased annually on the first day of each year, beginning in 2020 and ending in 2029, by an amount equal to the lesser of (A) four percent (4%) of the shares of the Registrant’s Common Stock outstanding on the last day of the immediately preceding fiscal year and (B) such smaller number of Shares as determined by the Board of Directors.
INCORPORATION BY REFERENCE OF CONTENTS
OF REGISTRATION STATEMENTS ON FORM S-8
Pursuant to General Instruction E of Form S-8, the contents of the Registration Statements on Form S-8 filed with the SEC on
December 13, 2019 (File No. 333-235480),
August 14, 2020 (File No. 333-246083) and
April 9, 2021 (File No. 333-255159) are incorporated by reference herein.
Reference is made under this Item 8 to the exhibit index included in this Registration Statement.
Exhibit Index
| | | | Incorporated by Reference | | | | |
Exhibit Number | | Exhibit Description | | Form | | Date | | Number | | Filed Herewith |
4.1 | | | | 8-K | | 10-17-17 | | 3.1 | | |
4.2 | | | | 8-K | | 11-7-19 | | 3.1 | | |
4.3 | | | | 8-K | | 11-7-19 | | 3.2 | | |
4.4 | | | | 10-K | | 3-29-21 | | 4.1 | | |
4.5 | | | | S-1/A | | 9-18-17 | | 4.2 | | |
4.6 | | | | 8-K | | 11-7-19 | | 10.21 | | |
4.7 | | | | 10-K | | 3-30-20 | | 10.24 | | |
4.8 | | | | | | | | | | X |
5.1 | | | | | | | | | | X |
23.1 | | | | | | | | | | X |
23.2 | | | | | | | | | | X |
24.1 | | | | | | | | | | X |
107 | | | | | | | | | | X |
# | Indicates management contract or compensatory plan. |
SIGNATURES
Pursuant to the requirements of the Securities Act of 1933, the Registrant certifies that it has reasonable grounds to believe that it meets all of the requirements for filing on Form S-8 and has duly caused this registration statement to be signed on its behalf by the undersigned, thereunto duly authorized, in Toronto, Province of Ontario, Canada, on this 8th day of April, 2022.
| Venus Concept Inc. |
| | |
| By: | /s/ Domenic Serafino |
| | Domenic Serafino |
| | Chief Executive Officer |
KNOW ALL PERSONS BY THESE PRESENTS, that each person whose signature appears below does hereby constitute and appoint Domenic Serafino and Domenic Della Penna and each of them, with full power of substitution and full power to act without the other, his or her true and lawful attorney-in-fact and agent to act for him or her in his or her name, place and stead, in any and all capacities, to sign any and all amendments (including post-effective amendments) to this registration statement, and to file this registration statement, with all exhibits thereto, and other documents in connection therewith, with the SEC, granting unto said attorneys-in-fact and agents, and each of them, full power and authority to do and perform each and every act and thing requisite and necessary to be done in order to effectuate the same as fully, to all intents and purposes, as they or he or she might or could do in person, hereby ratifying and confirming all that said attorneys-in-fact and agents, or any of them, may lawfully do or cause to be done by virtue hereof.
Pursuant to the requirements of the Securities Act of 1933, this registration statement has been signed by the following persons in the capacities and on the date indicated.
Signature | | Title | | Date |
| | | | |
/s/ Domenic Serafino | | Chief Executive Officer and Director (Principal Executive Officer) | | April 8, 2022 |
Domenic Serafino | | |
| | | | |
/s/ Domenic Della Penna | | Chief Financial Officer (Principal Financial and Accounting Officer) | | April 8, 2022 |
Domenic Della Penna | | |
| | | | |
/s/ Scott Barry | | Chairman and Director | | April 8, 2022 |
Scott Barry | | |
| | | | |
/s/ Garheng Kong, M.D. | | Director | | April 8, 2022 |
Garheng Kong, M.D. | | |
| | | | |
/s/ Louise Lacchin | | Director | | April 8, 2022 |
Louise Lacchin | | |
| | | | |
/s/ Fritz LaPorte | | Director | | April 8, 2022 |
Fritz LaPorte | | |
| | | | |
/s/ Anthony Natale, M.D. | | Director | | April 8, 2022 |
Anthony Natale, M.D. | | |
| | | | |
/s/ Keith Sullivan | | Director | | April 8, 2022 |
Keith J. Sullivan | | |
| | |
/s/ S.Tyler Hollmig, M.D. | | Director | | April 8, 2022 |
S.Tyler Hollmig, M.D. | | |